首页> 外文期刊>Bioorganic and medicinal chemistry >Antitumor agents 216. Synthesis and evaluation of paclitaxel-camptothecin conjugates as novel cytotoxic agents.
【24h】

Antitumor agents 216. Synthesis and evaluation of paclitaxel-camptothecin conjugates as novel cytotoxic agents.

机译:抗肿瘤药216.紫杉醇-喜树碱偶联物的合成和评价作为新型细胞毒剂。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Five conjugates (16-20) composed of a paclitaxel and a camptothecin derivative joined by an imine linkage were synthesized and evaluated as cytotoxic agents and as inhibitors of DNA topoisomerase I. All of the conjugates were potent inhibitors of tumor cell replication with improved activity relative to camptothecin. Significantly, compounds 16-18 were more active than paclitaxel and camptothecin against HCT-8 (colon adenocarcinoma) cell replication, and the spectrum of activity was different from a simple mixture of paclitaxel and camptothecin. All of the conjugates were significantly less potent than camptothecin as inhibitors of human topoisomerase I in vitro with 16, 18, and 19 showing only marginal activity at 50 microM. Based on activity against drug-resistant cell line replication, one could conclude that the conjugates are simply acting as 'weak taxanes', but the spectrum of activity, particularly against MCF-7 and HCT-8, strongly suggests that a novel mechanism of action has been achieved through conjugation.
机译:合成了五种由紫杉醇和喜树碱衍生物(通过亚胺键连接)组成的共轭物(16-20),并作为细胞毒性剂和DNA拓扑异构酶I的抑制剂进行了评估。所有共轭物都是有效的肿瘤细胞复制抑制剂,相对活性得到改善喜树碱。重要的是,化合物16-18在抑制HCT-8(结肠腺癌)细胞复制方面比紫杉醇和喜树碱更具活性,其活性谱不同于紫杉醇和喜树碱的简单混合物。在体外,所有缀合物均比喜树碱具有更强的抗人拓扑异构酶I的能力,其中16、18和19仅在50 microM时显示边缘活性。基于抗药性细胞系复制的活性,可以得出结论,缀合物仅起“弱紫杉烷”的作用,但活性谱,特别是针对MCF-7和HCT-8的活性,强烈暗示了一种新的作用机制通过共轭实现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号